Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’re breaking down some of the key parts of a sweeping new health care bill today.
The need-to-know this morning
Johnson & Johnson kicked off the fourth-quarter earnings season with in-line profits and revenue slightly higher than the consensus estimate. For 2026, J&J guided to an earnings range that brackets consensus and a better-than-expected revenue forecast. You want actual numbers? Check them out here.
PBM reform revived in new health care bill
Congress has reached a deal on several health care policies that are part of a sweeping bill to fund the Health and Human Services Department. Many of these proposals were part of a deal Congress struck in December 2024 that quickly fell apart after then President-elect Trump and Elon Musk attacked it.Continue to STAT+ to read the full story…